Copyright Reports & Markets. All rights reserved.

Global Colloids (Blood Plasma) Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Colloids (Blood Plasma) Market Overview

      • 1.1 Product Overview and Scope of Colloids (Blood Plasma)
      • 1.2 Colloids (Blood Plasma) Segment by Type
        • 1.2.1 Global Colloids (Blood Plasma) Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Natural Type Colloids (Blood Plasma)
        • 1.2.3 Synthetic Type Colloids (Blood Plasma)
      • 1.3 Colloids (Blood Plasma) Segment by Application
        • 1.3.1 Colloids (Blood Plasma) Consumption Comparison by Application (2014-2025)
        • 1.3.2 Extensive Burns
        • 1.3.3 Massive Blood or Plasma Loss
        • 1.3.4 Hypovolemic Shock
        • 1.3.5 Others
      • 1.3 Global Colloids (Blood Plasma) Market by Region
        • 1.3.1 Global Colloids (Blood Plasma) Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Colloids (Blood Plasma) Market Size
        • 1.4.1 Global Colloids (Blood Plasma) Revenue (2014-2025)
        • 1.4.2 Global Colloids (Blood Plasma) Production (2014-2025)

      2 Global Colloids (Blood Plasma) Market Competition by Manufacturers

      • 2.1 Global Colloids (Blood Plasma) Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Colloids (Blood Plasma) Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Colloids (Blood Plasma) Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Colloids (Blood Plasma) Production Sites, Area Served, Product Types
      • 2.5 Colloids (Blood Plasma) Market Competitive Situation and Trends
        • 2.5.1 Colloids (Blood Plasma) Market Concentration Rate
        • 2.5.2 Colloids (Blood Plasma) Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Colloids (Blood Plasma) Production Market Share by Regions

      • 3.1 Global Colloids (Blood Plasma) Production Market Share by Regions
      • 3.2 Global Colloids (Blood Plasma) Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Colloids (Blood Plasma) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Colloids (Blood Plasma) Production
        • 3.4.1 North America Colloids (Blood Plasma) Production Growth Rate (2014-2019)
        • 3.4.2 North America Colloids (Blood Plasma) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Colloids (Blood Plasma) Production
        • 3.5.1 Europe Colloids (Blood Plasma) Production Growth Rate (2014-2019)
        • 3.5.2 Europe Colloids (Blood Plasma) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Colloids (Blood Plasma) Production (2014-2019)
        • 3.6.1 China Colloids (Blood Plasma) Production Growth Rate (2014-2019)
        • 3.6.2 China Colloids (Blood Plasma) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Colloids (Blood Plasma) Production (2014-2019)
        • 3.7.1 Japan Colloids (Blood Plasma) Production Growth Rate (2014-2019)
        • 3.7.2 Japan Colloids (Blood Plasma) Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Colloids (Blood Plasma) Consumption by Regions

      • 4.1 Global Colloids (Blood Plasma) Consumption by Regions
      • 4.2 North America Colloids (Blood Plasma) Consumption (2014-2019)
      • 4.3 Europe Colloids (Blood Plasma) Consumption (2014-2019)
      • 4.4 China Colloids (Blood Plasma) Consumption (2014-2019)
      • 4.5 Japan Colloids (Blood Plasma) Consumption (2014-2019)

      5 Global Colloids (Blood Plasma) Production, Revenue, Price Trend by Type

      • 5.1 Global Colloids (Blood Plasma) Production Market Share by Type (2014-2019)
      • 5.2 Global Colloids (Blood Plasma) Revenue Market Share by Type (2014-2019)
      • 5.3 Global Colloids (Blood Plasma) Price by Type (2014-2019)
      • 5.4 Global Colloids (Blood Plasma) Production Growth by Type (2014-2019)

      6 Global Colloids (Blood Plasma) Market Analysis by Applications

      • 6.1 Global Colloids (Blood Plasma) Consumption Market Share by Application (2014-2019)
      • 6.2 Global Colloids (Blood Plasma) Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Colloids (Blood Plasma) Business

      • 7.1 CSL Behring
        • 7.1.1 CSL Behring Colloids (Blood Plasma) Production Sites and Area Served
        • 7.1.2 Colloids (Blood Plasma) Product Introduction, Application and Specification
        • 7.1.3 CSL Behring Colloids (Blood Plasma) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Baxter
        • 7.2.1 Baxter Colloids (Blood Plasma) Production Sites and Area Served
        • 7.2.2 Colloids (Blood Plasma) Product Introduction, Application and Specification
        • 7.2.3 Baxter Colloids (Blood Plasma) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Grifols
        • 7.3.1 Grifols Colloids (Blood Plasma) Production Sites and Area Served
        • 7.3.2 Colloids (Blood Plasma) Product Introduction, Application and Specification
        • 7.3.3 Grifols Colloids (Blood Plasma) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Octapharma
        • 7.4.1 Octapharma Colloids (Blood Plasma) Production Sites and Area Served
        • 7.4.2 Colloids (Blood Plasma) Product Introduction, Application and Specification
        • 7.4.3 Octapharma Colloids (Blood Plasma) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Kedrion
        • 7.5.1 Kedrion Colloids (Blood Plasma) Production Sites and Area Served
        • 7.5.2 Colloids (Blood Plasma) Product Introduction, Application and Specification
        • 7.5.3 Kedrion Colloids (Blood Plasma) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Shanghai Raas
        • 7.6.1 Shanghai Raas Colloids (Blood Plasma) Production Sites and Area Served
        • 7.6.2 Colloids (Blood Plasma) Product Introduction, Application and Specification
        • 7.6.3 Shanghai Raas Colloids (Blood Plasma) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 CTBB
        • 7.7.1 CTBB Colloids (Blood Plasma) Production Sites and Area Served
        • 7.7.2 Colloids (Blood Plasma) Product Introduction, Application and Specification
        • 7.7.3 CTBB Colloids (Blood Plasma) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Hualan Bio
        • 7.8.1 Hualan Bio Colloids (Blood Plasma) Production Sites and Area Served
        • 7.8.2 Colloids (Blood Plasma) Product Introduction, Application and Specification
        • 7.8.3 Hualan Bio Colloids (Blood Plasma) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Rongsheng Pharmaceutical
        • 7.9.1 Rongsheng Pharmaceutical Colloids (Blood Plasma) Production Sites and Area Served
        • 7.9.2 Colloids (Blood Plasma) Product Introduction, Application and Specification
        • 7.9.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Boya Rongsheng
        • 7.10.1 Boya Rongsheng Colloids (Blood Plasma) Production Sites and Area Served
        • 7.10.2 Colloids (Blood Plasma) Product Introduction, Application and Specification
        • 7.10.3 Boya Rongsheng Colloids (Blood Plasma) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 B. Braun Medical
      • 7.12 Fresenius Kabi
      • 7.13 HOSPIRA
      • 7.14 Axa parenterals
      • 7.15 Fresenius Kabi(China)
      • 7.16 CR Double-Crane
      • 7.17 Kelun Group
      • 7.18 Shandong Qidu Pharmaceutical
      • 7.19 Shandong Hualu Pharmaceutical
      • 7.20 Minsheng Pharma
      • 7.21 Kanglepharm

      8 Colloids (Blood Plasma) Manufacturing Cost Analysis

      • 8.1 Colloids (Blood Plasma) Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Colloids (Blood Plasma)
      • 8.4 Colloids (Blood Plasma) Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Colloids (Blood Plasma) Distributors List
      • 9.3 Colloids (Blood Plasma) Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Colloids (Blood Plasma) Market Forecast

      • 11.1 Global Colloids (Blood Plasma) Production, Revenue Forecast
        • 11.1.1 Global Colloids (Blood Plasma) Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Colloids (Blood Plasma) Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Colloids (Blood Plasma) Price and Trend Forecast (2019-2025)
      • 11.2 Global Colloids (Blood Plasma) Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Colloids (Blood Plasma) Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Colloids (Blood Plasma) Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Colloids (Blood Plasma) Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Colloids (Blood Plasma) Production, Revenue Forecast (2019-2025)
      • 11.3 Global Colloids (Blood Plasma) Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Colloids (Blood Plasma) Consumption Forecast (2019-2025)
        • 11.3.2 Europe Colloids (Blood Plasma) Consumption Forecast (2019-2025)
        • 11.3.3 China Colloids (Blood Plasma) Consumption Forecast (2019-2025)
        • 11.3.4 Japan Colloids (Blood Plasma) Consumption Forecast (2019-2025)
      • 11.4 Global Colloids (Blood Plasma) Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Colloids (Blood Plasma) Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
        Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.

        The global colloids (blood plasma) industry is mature. The production of Human Albumin increase from 544.08 MT in 2010 to 805.38 MT in 2015, with an average growth rate of more than 9.60 %. The production of synthetic colloids increase from 42.03 Million Units in 2010 to 53.43 Million Units in 2015, with an average growth rate of more than 5.42 %.
        The production growth rate of hydroxyethyl starch colloid reduced obviously because Europe and USA banned the usage of HES solutions in patients with sepsis. At the same time, this stimulated the increase of growth rate in albumin colloids.
        The manufacturers and consumers of natural colloids and synthetic colloids are both concentrated in North America, Europe and China. North America is the largest manufacturer and consumer in natural colloids , however Europe occupies the largest share in the global synthetic market.

        The global Colloids (Blood Plasma) market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Colloids (Blood Plasma) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Colloids (Blood Plasma) market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        CSL Behring
        Baxter
        Grifols
        Octapharma
        Kedrion
        Shanghai Raas
        CTBB
        Hualan Bio
        Rongsheng Pharmaceutical
        Boya Rongsheng
        B. Braun Medical
        Fresenius Kabi
        HOSPIRA
        Axa parenterals
        Fresenius Kabi(China)
        CR Double-Crane
        Kelun Group
        Shandong Qidu Pharmaceutical
        Shandong Hualu Pharmaceutical
        Minsheng Pharma
        Kanglepharm

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Natural Type Colloids (Blood Plasma)
        Synthetic Type Colloids (Blood Plasma)

        Segment by Application
        Extensive Burns
        Massive Blood or Plasma Loss
        Hypovolemic Shock
        Others

        Buy now